BCL2 and diffuse large B-cell lymphoma: In the previous WHO/EORTC classification (2005) 7, 8, the heading of cutaneous diffuse large B‐cell lymphomas comprised several variants, including PCDLBCL‐LT, cases with peculiar morphology (T‐cell/histiocyte rich, plasmablastic) as well as diffuse lymphomas of centroblastic‐like cells, intermingled with a mixed inflammatory infiltrate and with variable expression of BCL2, which are named primary cutaneous diffuse large B‐cell lymphoma, other (PCDLBCL‐O).